STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Operating expenses:
Research and development	$ 15,293	$ 5,490	$ 33,605	$ 15,430
General and administrative	2,851	1,394	5,712	2,584
Total operating expenses	18,144	6,884	39,317	18,014
Loss from operations	(18,144)	(6,884)	(39,317)	(18,014)
Other income, net	1,384	150	1,638	483
Net loss	$ (16,760)	$ (6,734)	$ (37,679)	$ (17,531)
Per share information:
Net loss per share of common stock, basic and diluted	$ (5.25)	$ (3.93)	$ (15.83)	$ (10.80)
Weighted average common shares outstanding, basic and diluted	3,194,471	1,713,371	2,380,100	1,622,546